Copper–zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma

Multiple myeloma (MM) is an incurable B-cell malignancy. The proteasome inhibitor bortezomib (BTZ) is a frontline MM drug; however, intrinsic or acquired resistance to BTZ remains a clinical hurdle. As BTZ induces oxidative stress in MM cells, we queried if altered redox homeostasis promotes BTZ res...

Descripción completa

Detalles Bibliográficos
Autores principales: Salem, Kelley, McCormick, Michael L., Wendlandt, Erik, Zhan, Fenghuang, Goel, Apollina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309843/
https://www.ncbi.nlm.nih.gov/pubmed/25485927
http://dx.doi.org/10.1016/j.redox.2014.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309843/
https://www.ncbi.nlm.nih.gov/pubmed/25485927
http://dx.doi.org/10.1016/j.redox.2014.11.002

Ejemplares similares